These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Pseudoscleroderma or scleroderma coexisting with phenylketonuria]. Jablonska S; Stachow A Ann Dermatol Syphiligr (Paris); 1972; 99(3):257-62. PubMed ID: 4654109 [No Abstract] [Full Text] [Related]
8. [Scleroderma-like lesions and phenylketonuria (PKU). Role of hyperphenylalaninemia, efficacy of diet (3 cases)]. Bodemer C; Bonnefont JP; Saudubray JM; Teillac D; De Prost Y Ann Dermatol Venereol; 1989; 116(11):798-800. PubMed ID: 2619165 [No Abstract] [Full Text] [Related]
9. [A case of phenylketonuria complicated by scleroderma]. Bulakhova LO Pediatr Akus Ginekol; 1973; 1():30-1. PubMed ID: 4705053 [No Abstract] [Full Text] [Related]
10. [Our experiences with treatment of phenylketonuria]. Tresohlavá Z; Brachfeld K; Svatý J Cesk Pediatr; 1969 Jun; 24(6):522-8. PubMed ID: 5792287 [No Abstract] [Full Text] [Related]
11. [Pseudosclerodermatous lesions of the skin and muscles in a 19-month-old girl with phenylketonuria]. Krauze M; Marszał E; Jamroz E; Kajor M Pol Tyg Lek; 1989 Jan; 44(4):99-100. PubMed ID: 2798215 [No Abstract] [Full Text] [Related]
12. Scleroderma-like skin indurations in a child with phenylketonuria: a clinicopathologic correlation and review of the literature. Nova MP; Kaufman M; Halperin A J Am Acad Dermatol; 1992 Feb; 26(2 Pt 2):329-33. PubMed ID: 1569253 [TBL] [Abstract][Full Text] [Related]
13. [Experience with treatment of children with phenylketonuria]. Lebedev BV; Bliumina MG; D'iachkova AIa; Blagoslavova EI; Mirzoiants NS Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(10):1521-5. PubMed ID: 5369950 [No Abstract] [Full Text] [Related]
14. [Successful dietetic treatment of phenylketonuria using "phenylalanine-poor protein hydrolysate Berlin-Chemie". 2. EEG findings and convulsions]. Keller D; Degen R; Theile H Dtsch Gesundheitsw; 1969 Feb; 24(9):403-11. PubMed ID: 5376413 [No Abstract] [Full Text] [Related]
15. [Phenylketonuria: contribution of clinical psychology to the overall comprehension of the disease]. Rapoport D; Richardet JM Rev Neuropsychiatr Infant; 1975 Feb; 23(2):111-27. PubMed ID: 1096267 [No Abstract] [Full Text] [Related]
17. [EEG-records for indicating the termination of dietary treatment in phenylketonuria?]. Lässker G; Degen R; Theile H Padiatr Padol; 1973; 8(2):187-94. PubMed ID: 4698431 [No Abstract] [Full Text] [Related]
18. [Phenylketonuria coexisting with Down's syndrome and scleroderma]. Goncerzewicz M; Socha J; Krawczyński M; Białecki M; Ignyś I Wiad Lek; 1977 Nov; 30(22):1767-9. PubMed ID: 146313 [No Abstract] [Full Text] [Related]
19. [Oral findings in phenylketonuria with early and late dietetic therapy (author's transl)]. Franke W; Dyrná G; Wegner H Zahn Mund Kieferheilkd Zentralbl; 1982; 70(3):211-6. PubMed ID: 6214107 [No Abstract] [Full Text] [Related]
20. The management of phenylketonuria (PKU). McGill JJ Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():55-7. PubMed ID: 11400785 [No Abstract] [Full Text] [Related] [Next] [New Search]